USPTO serial 88232438
SILENT DESIGN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 9, 2024
- Examiner
- ANKRAH, NAAKWAMA S
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SILENT DESIGN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer Theis
Jennifer Theis CROWELL & MORINGP.O. BOX 10395CHICAGO, IL 60610UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical reagents other than for medical or veterinary purposes; chemical preparations for scientific purposes, including non-therapeutic ingredients used in pharmaceutical manufacture; diagnostic chemicals for scientific or research use, namely, reagents used in laboratory for scientific purposes; diagnostic reagents and diagnostic preparations, other than for medical or veterinary purposes; reagents for hematology analysis for scientific or research use; reagents for reticulocyte analysis for scientific or research use; reagents for blood coagulation analysis for scientific or research use; reagents for urinalysis for scientific or research use; reagents for immunoassay for scientific or research use; reagents for clinical chemistry testing for scientific or research use; reagents for gene test for scientific or research use; lysing solutions, namely, reagents used for hemolysing whole blood sample for scientific purposes; chemical reagent stains for industrial use; chemicals, namely, sheath solutions for industrial use; reference control chemicals for industrial use; chemical reference materials for industrial use; chemical agents, namely, quality control standard solutions and quality control chemicals for industrial use for testing and calibrating medical apparatus and reagents; hematology control chemicals for testing and calibrating medical apparatus and reagents; hematology control chemicals for industrial use; standard serum for scientific or research use; control serum for scientific or research use; biochemical standard serum for scientific or research use; biochemical control serum for scientific or research use; chemical agents, namely, quality control standard solutions and quality control chemicals for testing and calibrating medical apparatus and reagents; stains for medical or clinical laboratory use; stains for hematology analysis for medical or clinical laboratory use; stains for reticulocyte analysis for medical or clinical laboratory use; stains for urinalysis for medical or clinical laboratory use; stains for immunoassay for medical or clinical laboratory use | ACTIVE | — |
| 005 | Sanitary preparations for medical use; diagnostic reagents and diagnostic preparations for medical or veterinary purposes; chemical reagents for medical or veterinary purposes; testing reagents for clinical medical or medical diagnostic use; reagents for hematology analysis for clinical medical or medical diagnostic use; reagents for blood analysis for clinical medical or medical diagnostic use; reagents for white blood cell analysis for clinical medical or medical diagnostic use; reagents for immature cell analysis for clinical medical or medical diagnostic use; reagents for hemoglobin analysis for clinical medical or medical diagnostic use; reagents for reticulocyte analysis for clinical medical or medical diagnostic use; reagents for erythrocyte analysis for clinical medical or medical diagnostic use; reagents for nucleated red cell analysis for clinical medical or medical diagnostic use; reagents for blood coagulation analysis for medical or veterinary purposes; reagents for urinalysis for medical or veterinary purposes; reagents for urinary sediment analysis for medical or veterinary purposes; reagents for immunoassay for medical or veterinary purposes; reagents for bacteria analysis for medical or veterinary purposes; reagents for clinical chemistry testing for medical or veterinary purposes; reagents for genetic test for medical or veterinary purposes; reagents for protein test for medical or veterinary purposes; reagents for cancer recurrence prediction test for medical or veterinary purposes; reagents for anticancer drug sensitivity prediction test for medical or veterinary purposes; diluents for clinical medical or medical diagnostic use; diluents for hematology analysis for medical or veterinary purposes; diluents for reticulocyte analysis for medical or veterinary purposes; diluents for urinalysis for medical or veterinary purposes; diluents for immunoassay for medical or veterinary purposes; medical diagnostic reagents and solutions, namely, lysing solutions and reagents and hemolytic lysing solutions and reagents for hemolysing whole blood sample for medical or veterinary purposes; medical diagnostic reagents and solutions, namely, sheath solutions to be used in detecting analyte using flow cytometry for medical use; hematology control reagents for medical use; reference control reagents for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sysmex Corporation
- Other trademarks owned by Sysmex Corporation
- Other trademarks owned by Sysmex Corporation
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named SILENT DESIGN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 9, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 9, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 5, 2023 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Oct 5, 2023 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Oct 5, 2023 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Apr 18, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 17, 2023 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Apr 17, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 12, 2023 | EXT5 | SOU EXTENSION 5 FILED | — |
| Apr 12, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 9, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 7, 2022 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Nov 7, 2022 | EXT4 | SOU EXTENSION 4 FILED | — |
| Nov 7, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 4, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 2, 2022 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 2, 2022 | EXT3 | SOU EXTENSION 3 FILED | — |
| May 2, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 12, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 10, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Nov 10, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| Nov 10, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 11, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 7, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 7, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 7, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 8, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 13, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 13, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 23, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 10, 2020 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Sep 4, 2020 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Sep 2, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 1, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 1, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 1, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 31, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 31, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 31, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 12, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 12, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 4, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jan 6, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 21, 2019 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Nov 21, 2019 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Nov 21, 2019 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Nov 6, 2019 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 29, 2019 | ALIE | ASSIGNED TO LIE | — |
| Oct 15, 2019 | ALIE | ASSIGNED TO LIE | — |
| Mar 26, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 26, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 26, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 26, 2019 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Mar 26, 2019 | ISSR | WITHDRAWN FROM ISSUE - SENIOR ATTORNEY REQUEST | — |
| Mar 26, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 26, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 6, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 20, 2019 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Feb 15, 2019 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Feb 7, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 31, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 8, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 20, 2018 | NWAP | NEW APPLICATION ENTERED | — |